...
首页> 外文期刊>International journal of gynecological pathology: Official journal of the International Society of Gynecological Pathologists >The outcome for women with microinvasive cervical cancer with stromal invasion 1 mm or less: Should we always re-excise?
【24h】

The outcome for women with microinvasive cervical cancer with stromal invasion 1 mm or less: Should we always re-excise?

机译:对于基质浸润小于或等于1毫米的微浸润宫颈癌妇女的预后:我们应该始终重新锻炼吗?

获取原文
获取原文并翻译 | 示例
           

摘要

To assess the management and outcome for women with microinvasive cervical cancer with stromal invasion 1 mm or less, examining the impact of re-excision. A retrospective cohort study with interval analysis performed between December 2000 and December 2010. Sheffield Gynaecological Cancer Centre and Jessop Wing Colposcopy Unit, Sheffield, UK. Women diagnosed with microinvasive cervical cancer with stromal invasion 1 mm or less during the allocated study period. Methods used is a retrospective cohort study. Risk of recurrence and mortality from disease; incidence of residual disease in repeat excision specimens. A total of 140 women were identified as having microinvasive cervical cancer with stromal invasion 1 mm or less. Sixty-three (45%) had a completely excised lesion; 77 (55%) had an incompletely excised lesion at first treatment. Fifty-five women underwent repeat excision. No residual disease was found in the majority (n=40; 73%). No women suffered disease recurrence or died from disease during the allocated study period. Outcome for women with microinvasive cervical cancer with stromal invasion 1 mm or less is excellent. Repeat excision is associated with very low rates of residual disease. A more conservative approach to follow-up incorporating HPV testing should be explored.
机译:为了评估间质浸润小于或等于1毫米的微浸润宫颈癌妇女的管理和结果,研究再次切除的影响。在2000年12月至2010年12月间进行了一项回顾性队列研究,并进行了时间间隔分析。英国谢菲尔德谢菲尔德妇科癌症中心和杰索普翼阴道镜科。在分配的研究期间,被诊断患有基质浸润不超过1毫米的微浸润宫颈癌妇女。使用的方法是一项回顾性队列研究。疾病复发和死亡的风险;重复切除标本中残留疾病的发生率。总共有140名妇女被诊断为间质浸润为1毫米或更小的微浸润性宫颈癌。 63例(45%)病变完全切除。 77(55%)位患者在初次治疗时切除的病变不完全。五十五名妇女进行了重复切除。在大多数患者中未发现残留疾病(n = 40; 73%)。在分配的研究期内,没有妇女复发或死于疾病。对于基质浸润小于或等于1毫米的微浸润型宫颈癌妇女,治疗效果极佳。重复切除与残留疾病的发生率非常低有关。应该探索一种更保守的方法,将HPV检测纳入随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号